Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVOID: ICG for Anastomotic Leakage
NCT04712032Phase 3Unknown
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indocyanine green in colorectal cancer (CRC), Crohn's disease, sponsored by Leiden University Medical Center. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
colorectal cancer (CRC)Crohn's disease
Beyond the preview
Go deeper on NCT04712032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712032.